We are live on ! Find out more
LI

LMCG Investments Portfolio holdings

AUM $1.87B
1-Year Est. Return 50.61%
This Fund
S&P 500
This Quarter Est. Return
+12.85%
1 Year Est. Return
+50.61%
3 Year Est. Return
+124.92%
5 Year Est. Return
10 Year Est. Return
AUM
$1.6B
AUM Growth
+$88.6M
Cap. Flow
-$48.8M
Cap. Flow %
-3.06%
Top 10 Hldgs %
27.87%
Holding
232
New
4
Increased
49
Reduced
146
Closed
7

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$13.2M
2
NOC icon
Northrop Grumman
NOC
+$9.09M
3
ZBH icon
Zimmer Biomet
ZBH
+$6.93M
4
NEM icon
Newmont
NEM
+$5.77M
5
ENPH icon
Enphase Energy
ENPH
+$4.77M

Sector Composition

Rank Sector Weight
1 Technology 26.6%
2 Financials 15.03%
3 Healthcare 10.3%
4 Industrials 8.69%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XMLV icon
126
Invesco S&P MidCap Low Volatility ETF
XMLV
$748M
$2.32M 0.15%
37,591
+4,315
+13% +$262K
AER icon
127
AerCap
AER
$23.8B
$2.3M 0.14%
19,646
-958
-5% -$104K
DTE icon
128
DTE Energy
DTE
$29.1B
$2.26M 0.14%
17,053
-709
-4% -$95.3K
MDT icon
129
Medtronic
MDT
$112B
$2.24M 0.14%
25,709
+2,515
+11% +$213K
PGR icon
130
Progressive
PGR
$125B
$2.15M 0.13%
8,041
NEM icon
131
Newmont
NEM
$119B
$2.09M 0.13%
35,851
-108,079
-75% -$5.77M
GILD icon
132
Gilead Sciences
GILD
$165B
$1.97M 0.12%
17,797
-13,316
-43% -$1.42M
PANW icon
133
Palo Alto Networks
PANW
$297B
$1.92M 0.12%
9,378
ELV icon
134
Elevance Health
ELV
$85.5B
$1.91M 0.12%
4,915
-2,057
-30% -$827K
XLV icon
135
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$1.83M 0.11%
13,542
+1,284
+10% +$173K
DGRO icon
136
iShares Core Dividend Growth ETF
DGRO
$43.5B
$1.75M 0.11%
27,328
-1,067
-4% -$65.1K
MNST icon
137
Monster Beverage
MNST
$88.5B
$1.71M 0.11%
27,318
-169
-0.6% -$10.3K
SHEL icon
138
Shell
SHEL
$245B
$1.69M 0.11%
24,042
-299
-1% -$20K
GWX icon
139
State Street SPDR S&P International Small Cap ETF
GWX
$913M
$1.68M 0.11%
45,200
DVN icon
140
Devon Energy
DVN
$47.3B
$1.65M 0.1%
51,984
+902
+2% +$28.7K
RELX icon
141
RELX
RELX
$62B
$1.53M 0.1%
28,072
-1,518
-5% -$80.3K
AZN icon
142
AstraZeneca
AZN
$250B
$1.52M 0.1%
10,876
-578
-5% -$81K
PFE icon
143
Pfizer
PFE
$153B
$1.52M 0.1%
62,597
+2,284
+4% +$53.3K
QVMT
144
Invesco S&P 500 Concentrated QVM ETF
QVMT
$134M
$1.51M 0.09%
29,113
+3,344
+13% +$167K
PM icon
145
Philip Morris
PM
$295B
$1.5M 0.09%
8,233
AMLP icon
146
Alerian MLP ETF
AMLP
$12.8B
$1.44M 0.09%
29,433
+3,360
+13% +$163K
EPD icon
147
Enterprise Products Partners
EPD
$81.7B
$1.43M 0.09%
46,176
HP icon
148
Helmerich & Payne
HP
$3.71B
$1.41M 0.09%
93,055
-27,109
-23% -$497K
MO icon
149
Altria Group
MO
$114B
$1.39M 0.09%
23,644
+1,397
+6% +$82K
CLH icon
150
Clean Harbors
CLH
$16.3B
$1.34M 0.08%
5,777
-285
-5% -$62.4K

Similar funds

LMCG Investments's Q2 2025 Portfolio in Review

As of Q2 2025, LMCG Investments held 232 positions worth $1.6B, up 5.9% from $1.51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

LMCG Investments withdrew a net $48.8M in Q2 2025, closing 7 positions and reducing 146 holdings. Its most notable exit was Zimmer Biomet, an estimated $6.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMCG Investments opened a new position in iShares Core S&P 500 ETF worth $1.03M.

  • LMCG Investments's largest Q2 2025 buy was iShares Core S&P 500 ETF: 1,652 shares worth $1.03M.
  • LMCG Investments added most to Regeneron Pharmaceuticals in Q2 2025, an estimated $10.7M increase.
  • LMCG Investments's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $13.2M.
  • LMCG Investments fully exited Zimmer Biomet in Q2 2025, selling an estimated $6.93M.
  • LMCG Investments's ten largest holdings make up 28% of its $1.6B portfolio in Q2 2025.
  • LMCG Investments opened 4 new positions and closed 7 in Q2 2025.
  • LMCG Investments's portfolio value rose 5.9% quarter-over-quarter to $1.6B.

Based on LMCG Investments's 13F filing for Q2 2025, filed 24 Jul 2025.